The US Patent and Trademark Office has awarded a specialist pharmaceutical company a patent for a cannabidiol treatment of Fragile X Syndrome – a genetic condition. Other items include news from Australia, Latin America, the EU and the US ...
Restricted content. Do you want to read more?
Sign up NOW for 7 days FREE TRIAL and access our briefings section
CBD-Intel provides impartial, independent and premium market and regulatory analysis, legal tracking, and quantitative data for the cannabidiol (CBD) sector worldwide. Most content is available to subscribers only.